When robotic-assisted knee replacement technology began gaining traction, it was often framed as the next leap forward in orthopedic surgery, a tool promising greater precision, improved alignment and better long-term outcomes.
But recent population-level data is prompting a more nuanced conversation about what the technology actually delivers today.
For Daniel Pincus, MD, PhD, a primary author of the study and an orthopedic surgeon at the Sunnybrook Holland Orthopaedic & Arthritic Centre in Toronto, the goal was not to challenge innovation, but to better understand how it performs in real-world practice, especially as adoption accelerates across health systems.
A recent study led by Dr. Pincus, published in The Journal of Arthroplasty, examined nearly 75,000 total knee replacements performed across Ontario, Canada, between 2019 and 2023. The findings were clear: Patients who underwent robotic-assisted procedures experienced a 2% rate of major surgical complications within one year, compared to 1% for conventional knee replacements.
A signal — not a verdict
The study arrives at a time when robotic adoption in arthroplasty is rising rapidly. In Ontario alone, use of the technology nearly tripled over the study period. Still, Dr. Pincus is careful not to overstate the implications.
He emphasized that the research should be viewed as one contribution to a broader and still-developing body of evidence, not a final answer on the value of robotic-assisted surgery.
A key factor shaping the results is the learning curve. Unlike high-volume centers that may have used robotic systems for years, the surgeons included in the study were largely in earlier stages of adoption.
“It was not studied in an environment in which robotic surgery has been practiced for 15 years at very high volumes, and essentially everybody who was included in this study was still on their learning curve,” Dr. Pincus said.
That context matters. When new surgical workflows are introduced, often involving longer operative times, additional pin sites and more complex setup, incremental risks may emerge, particularly in the early phases.
Understanding the trade-offs
Robotic-assisted procedures often require additional steps compared to conventional surgery, including longer incisions, extra fixation points and extended anesthesia time. These factors can contribute to higher complication rates in the short term.
Dr. Pincus said the findings align with what surgeons might reasonably expect when introducing a more complex technique.
“When there is a practice change such that you are using a new technology differently, it takes longer, you have to make the incision longer, and there are extra pin sites, so it is not surprising that the revision rate is a little bit higher within the first year,” he said.
At the same time, the study did not evaluate several outcomes often cited as potential advantages of robotics, such as implant positioning accuracy or patient-reported satisfaction.
He noted that the research focused specifically on complications and did not assess other outcomes like patient-reported results or radiographic alignment, meaning potential benefits in those areas were outside the scope of the analysis.
Why adoption continues to grow
Despite mixed evidence, the momentum behind robotic arthroplasty continues to build. For Dr. Pincus, that trend reflects a combination of clinical ambition, patient expectations and broader industry dynamics.
He said surgeons are always looking for ways to improve outcomes, particularly because some patients remain dissatisfied after knee replacement surgery. New technology naturally becomes part of that effort.
At the same time, patient demand and marketing play a growing role. Some patients actively seek out robotic-assisted procedures, viewing them as more advanced.
“There are patients who come in and will ask specifically for a robotic total knee at my center,” Dr. Pincus said.
The importance of volume and consistency
One of the most consistent findings in arthroplasty research has little to do with technology itself: Outcomes are closely tied to surgical volume and experience.
“I think whatever you are going to do, you should probably choose a lane and do it well, because the one thing that has really been shown to drive outcomes in arthroplasty over the last 20 years is volume,” Dr. Pincus said.
High-volume surgeons, whether using robotic systems or conventional techniques, tend to achieve better results. In that sense, new technology does not replace the fundamentals of surgical expertise.
He also emphasized that innovation should not come at the expense of improving existing components of care, including implant design. “We should not forget that there are still a lot of things that can be improved with total knee arthroplasty on the implant side,” he said.
A familiar pattern in surgical innovation
The debate surrounding robotic knee replacement reflects a broader and recurring challenge in medicine: how to balance innovation with evidence.
Dr. Pincus pointed to past examples where new technologies either transformed care or ultimately failed to deliver on their promise. The difficulty, he said, lies in determining which path a new innovation will follow.
“We want to make these procedures better, but we do not want to go backwards and make them worse while trying to improve them, because the outcomes are already quite good,” he said.
For him, one guiding principle is whether a new approach makes sense from a practical and biological standpoint. In the case of robotic knee replacement, the modest increase in early complications is consistent with the added procedural complexity.
What health systems should consider
As governments and health systems invest more heavily in robotic platforms, the study offers a pragmatic lens for decision-making.
In Ontario, where significant public investment in robotic technology is underway, Dr. Pincus said the current evidence suggests a nuanced reality.
“The evidence would suggest that there likely will be a slightly higher revision rate as a result of that, with an uncertain benefit in terms of patient-reported outcomes and higher cost,” he said.
That does not mean the technology lacks value. Rather, it highlights the importance of thoughtful implementation, including training, case selection and realistic expectations.
The path forward
For Dr. Pincus, the conversation is not about rejecting robotics, but about refining how it is used, and ensuring that enthusiasm does not outpace evidence.
As orthopedic surgery continues to evolve, the central question remains the same: Which innovations meaningfully improve patient care, and which simply add complexity?
For now, robotic-assisted knee replacement occupies a middle ground, promising, widely adopted and still being defined.
And in that uncertainty, there is an opportunity for the field to proceed deliberately, guided not by momentum alone, but by data, experience and a clear focus on patient outcomes.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
